Boston Scientific Corp
Change company Symbol lookup
Select an option...
BSX Boston Scientific Corp
CDTX Cidara Therapeutics Inc
XBTAX BlackRock Long Term Municipal Advantage Trust
PBYA Probility Media Corp
RA Brookfield Real Assets Income Fund Inc.
PAA Plains All American Pipeline LP
GOOGL Alphabet Inc
WFC Wells Fargo & Co
BAC Bank of America Corp

Health Care : Health Care Equipment & Supplies | Large Cap Growth
Company profile

Boston Scientific Corporation is a developer, manufacturer and marketer of medical devices that are used in a range of interventional medical specialties. The Company offers its products by seven businesses: Interventional Cardiology, Cardiac Rhythm Management, Endoscopy, Peripheral Interventions, Urology and Pelvic Health, Neuromodulation, and Electrophysiology. It operates in three segments: Cardiovascular, Rhythm Management and MedSurg. Its Cardiovascular segment consists of Interventional Cardiology and Peripheral Interventions businesses. Rhythm Management consists of Cardiac Rhythm Management and Electrophysiology businesses. MedSurg consists of Endoscopy, Urology and Pelvic Health, and Neuromodulation businesses. Its Interventional Cardiology product offerings include balloon catheters, rotational atherectomy systems, guide wires, guide catheters and embolic protection devices and diagnostic catheters used in percutaneous transluminal coronary angioplasty (PTCA) procedures.

Closing Price
Day's Change
0.10 (0.28%)
B/A Size
Day's High
Day's Low

10-day average volume:

Boston Scientific Announces May 2020 Virtual Conference Schedule

9:30 am ET May 6, 2020 (PR Newswire) Print

Boston Scientific Corporation (NYSE: BSX) will participate in three upcoming virtual investor conferences.

On May 13, 2020, Dan Brennan, executive vice president and chief financial officer, and Susie Lisa, vice president, Investor Relations, will participate in a 30-minute question-and-answer session with the host analyst at the BofA Securities 2020 Health Care Conference. The session will begin at approximately 8:20 a.m. EDT.

On May 19, 2020, Jeff Mirviss, executive vice president and president, Peripheral Interventions, Michael Jaff, D.O., vice president, clinical affairs, innovation and technology, Peripheral Interventions, and Susie Lisa will participate in a 40-minute question-and-answer session with the host analyst at the UBS Global Healthcare Conference. The session will begin at approximately 9:10 a.m. EDT.

On May 27, 2020, Mike Mahoney, chairman and chief executive officer, and Susie Lisa will participate in a 50-minute question-and-answer session with the host analyst at Bernstein's 36th Annual Strategic Decisions Conference. The session will begin at approximately 8 a.m. EDT.

A live webcast and replay of the webcast for each event will be accessible at investors.bostonscientific.com The replay will be available beginning approximately one hour following the completion of each event.

About Boston ScientificBoston Scientific transforms lives through innovative medical solutions that improve the health of patients around the world. As a global medical technology leader for 40 years, we advance science for life by providing a broad range of high performance solutions that address unmet patient needs and reduce the cost of healthcare. For more information, visit and connect on Twitter and Facebook.


Media: Katie Schur 508-683-5574 (office) Media Relations Boston Scientific Corporation

Investors: Susie Lisa, CFA 508-683-5565 (office) Investor Relations Boston Scientific Corporation

View original content to download multimedia:

SOURCE Boston Scientific Corporation

Earnings Calendar and Events Data provided by |Terms of Use| © 2020 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2020. All rights reserved.